小说阅读器,辰东

骨誘導(dǎo)因子(OGN)多克隆抗體(生物素標(biāo)記)

Western Blot; Sample: Rat Lung lysate
Primary Ab: 0.2μg/ml Biotin-Linked Polyclonal Antibody to Osteoglycin (OGN)
Second Ab: 0.2μg/ml HRP-Labeled Streptavidin (Catalog: IS089)

該抗體是針對OGN的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別OGN。

免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學(xué)：5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué)：5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。

雜志	參考文獻(xiàn)
Bone.	Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus. [pubmed:27836731]
Tohoku journal of experimental medicine	Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease. [pubmed:28824047]
Molecular Metabolism	Osteoglycin, a novel coordinator of bone and glucose homeostasis [Pubmed:29799418]
Journal of Experimental &?Clinical?Cancer?Research	Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway [Pubmed:29499765]
Journal of Human Hypertension	Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients [Pubmed:29867136]
Cell?Reports	Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue [Pubmed: 30332637]
J Clin Endocrinol Metab	Osteoglycin across the adult lifespan [34850904]

留言咨詢

編號	適用物種：Rattus norvegicus (Rat，大鼠)	應(yīng)用(僅供研究使用，不用于臨床診斷！)
RPC688Ra01	骨誘導(dǎo)因子(OGN)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
PAC688Ra01	骨誘導(dǎo)因子(OGN)多克隆抗體	WB; IHC; ICC; IP.
LAC688Ra71	骨誘導(dǎo)因子(OGN)多克隆抗體(生物素標(biāo)記)	WB; IHC; ICC.